Blood pressure-independent effects in rats with human renin and angiotensinogen genes

Hypertension

Volumn 35, Issue 2, 2000, Pages 587-594

  Mervaala, Eero ^d   Müller, Dominik N ^d   Schmidt, Folke ^d   Park, Joon Keun ^d   Gross, Volkmar ^d   Bader, Michael ^a   Breu, Volker ^b   Ganten, Detlev ^a   Haller, Hermann ^a   Luft, Friedrich C ^a,c  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c FRANZ VOLHARD CLINIC   (Germany)

^d NONE

Author keywords

Albuminuria; Angiotensin II; Angiotensinogen; Cell proliferation; Natriuresis; Renin

Indexed keywords

ALBUMIN; ANGIOTENSIN; ANGIOTENSINOGEN; HYDRALAZINE; HYDROCHLOROTHIAZIDE; KI 67 ANTIGEN; RENIN; RENIN INHIBITOR; RESERPINE; RO 66 1132; UNCLASSIFIED DRUG;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY VASCULAR RESISTANCE; DIURESIS; GLOMERULUS FILTRATION RATE; HEART HYPERTROPHY; KIDNEY BLOOD FLOW; KIDNEY INJURY; KIDNEY TUBULE PRESSURE; MACROPHAGE; MALE; MONOCYTE; NATRIURESIS; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION; TRANSGENIC ANIMAL;

EID: 0343484977     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.2.587     Document Type: Article

References (37)

1. Asscher AW, Anson SG. A vascular permeability factor of renal origin. Nature. 1963;196:1097-1100.
2. Robertson AL, Khairallah PA. Effects of angiotensin II and some analogues on vascular permeability in the rabbit. Circ Res. 1972;31: 923-931.
3. Kincaid-Smith P, Hobbs JB, Friedman A, Mathews DC. Structured and ultrastructured alterations in mesenteric and renal arterioles following infusions of vasoactive agents. In: Genest J, Koiw E, eds. Hypertension '72. Berlin, Germany: Springer; 1972:97.
4. Giese J. Renin, angiotensin and hypertensive vascular damage: a review. Am J Med. 1973;55:315-332.
5. Dzau VJ, Re R. Tissue angiotensin system in cardiovascular medicine: a paradigm shift? Circulation. 1994;89:493-498.
6. Hollenberg NK, Fisher NDL, Price DA. Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruptions of the renin system. Hypertension. 1998;32: 387-392.
7. Pratt RE. Angiotensin and the control of cardiovascular structure. J Am Soc Nephrol. 1999;10:S120-S128.
8. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989;13:305-314.
9. Bunkenburg B, con Amelsvoort T, Rogg H, Wood JM. Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension. 1992;20:746-754.
10. Inagami T. Molecular biology and signalling of angiotensin receptors: an overview. J Am Soc Nephrol. 1999;10:S2-S7.
11. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J. Schwartz SM. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;19:464-474.
12. Jaimes EA, Galceran JM, Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int. 1998;54:775-784.
13. Tanaka R, Sugihara K, Tatematsu A, Fogo A. Internephron heterogeneity of growth factors and sclerosis-modulation of platelet derived growth factor by angiotensin II. Kidney Int. 1995;47:131-139.
14. Kagami S, Border WA, Miller DA, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor b in rat glomerular mesangial cells. J Clin Invest. 1994;93:2431-2437.
15. deBlois D, Lombardi DM, Su EJ, Clowes AW, Schwartz SM, Giachelli CM. Angiotensin II induction of osteopontin expression and DNA replication in rat arteries. Hypertension. 1996;28:1055-1063.
16. Su EJ, Lombardi DM, Siegal J, Schwartz SM. Angiotensin II induces vascular smooth cell replication independent of blood pressure. Hypertension. 1998;31:1331-1337.
17. Luft FC, Mervaala EMA, Muller DN, Gross V, Schmidt F, Park J-K, Schmitz C, Lippoldt A, Breu V, Dechend R, Dragun D, Schneider W, Ganten D, Haller H. Hypertension-induced end-organ damage: a new transgenic approach to an old problem. Hypertension. 1999;33: 212-218.
18. Mervaala EMA, Muller DN, Park J-K, Schmidt F, Löhn M, Breu V, Dragun D, Ganten D, Haller H, Luft FC. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension. 1999;33:389-395.
19. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest. 1986; 77:1993-2000.
20. Ganten D, Wagner J, Zeh K, Bader M, Michel JP, Paul M, Zimmermann F, Ruf P, Hilgenfeldt U, Ganten U, Kaling M, Bachmann S, Fukamizu A, Mullins JJ, Murakami K. Species specificity of renin kinetics in transgenic rats harboring human renin and angiotensinogen genes. Proc Natl Acad Sci USA. 1992;89:7806-7810.
21. Bohlender J, Fukamizu A, Lippoldt A, Nomura T, Dietz R, Ménard J, Murakami K, Luft FC, Ganten D. High human renin hypertension in transgenic rats. Hypertension. 1997;29:428-434.
22. Muller DN, Fischli W, Clozel J-P, Hilgers KF, Bohlender J, Menard J. Busjahn A, Ganten D, Luft FC. Local angiotensin II generation in the rat heart: role of renin uptake. Circ Res. 1998;82:13-20.
23. Dehmel B, Mervaala E, Lippoldt A, Gross V, Bohlender J, Ganten D, Luft FC. Pressure-natriuresis and -diuresis in transgenic rats harboring both human renin and human angiotensinogen genes. J Am Soc Nephrol. 1998;9:2212-2222.
24. van Kats JP, Sassen LMA, Danser AHJ, Polak MPJ, Soei LK, Derkx FHM, Schalekamp MADH, Verdouw PD. Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikiren. Br J Pharmacol. 1996;117:891-901.
25. Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991; 17:626-635.
26. Mazzolai L, Nussberger J, Aubert J-F, Brunner DB, Gabbiani G, Brunner HR, Pedrazzini T. Blood-pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension. 1998;31:1324-1330.
27. Montgomery HE, Kiernan LA, Whitworth CE, Fleming S, Unger T, Gohlke P, Mullins JJ, McEwan JR. Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27. J Hypertens. 1998;16:635-643.
28. Hannken T, Schroeder R, Stahl RAK, Wolf G. Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals. Kidney Int. 1998;54:1923-1933.
29. Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkow M, Stahl RAK, Macharzina R, Bräsen JH, Meinertz T, Munzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int. 1999;55:252-260.
30. Von Thun AM, Vari RC, El-Dahr SS, Navar LG. Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion. Am J Physiol. 1994;266:F120-F128.
31. Zou L-X, Von Thun AM, Hymel A, Ono H, Navar LG. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats. Hypertension. 1996;28:669-677.
32. 1 receptor blockade modify pressure-natriuresis by different mechanisms in rats with human renin and angiotensinogen genes. J Am Soc Nephrol. 1999;10: 1669-1680.
33. Kato H, Iwai N, Inui H, Kimoto K, Uchiyama Y, Inagami T. Regulation of vascular angiotensin release. Hypertension. 1993;21: 446-454.
34. Urata H, Healey B, Stewart RW, Bumpus FM, Husain A. Angiotensin II forming pathways in normal and failing human hearts. Circ Res. 1990;66:883-890.
35. Wolf G, Ziyadeh FN, Thaiss F, Tomaszweski J, Caron RJ, Wenzel U, Zahner G, Helmchen U, Stahl RA. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells: role of the angiotensin type 2 receptor. J Clin Invest. 1997;100: 1047-1058.
36. Mai M, Geiger H, Hilgers KF, Veelken R, Mann JFE, J Dämmrich, Luft FC. Interstitial accumulation of extracellular matrix molecules early in the development of hypertensive renal injury. Hypertension. 1993;22:754-765.
37. Whitworth CE, Fleming S, Kotelevtsev Y, Manson L, Brooker GA, Cumming AD, Mullins JJ. A genetic model of malignant phase hypertension in rats. Kidney Int. 1995;47:529-535.